KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis C
Condition: Hepatitis C, Chronic Interventions: Drug: KW-136 capsule; Drug: Sofosbuvir Sponsors: Kawin Technology Share-holding Co., Ltd.; KawinGreen Biotech Co., Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials